SOX2 was revealed to be amplified and overexpressed in gastric cancers, and depletion of SOX2 markedly inhibited cell proliferation and tumor growth in breast cancer through downregulating CCND1 and PARP27. This evidence concerns the gene SOX2 and breast carcinoma.